58 related articles for article (PubMed ID: 19372944)
1. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2008 May; 3(3):362-7. PubMed ID: 19372991
[TBL] [Abstract][Full Text] [Related]
3. HIV vaccines: can mucosal CD4 T cells be protected?
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and function of protective T cell immune responses in HIV.
Betts MR; Harari A
Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
6. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
7. Role of HIV-1-specific CD4 T cells.
Harari A; Cellerai C; Pantaleo G
Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
Turnbull EL; Wong M; Wang S; Wei X; Jones NA; Conrod KE; Aldam D; Turner J; Pellegrino P; Keele BF; Williams I; Shaw GM; Borrow P
J Immunol; 2009 Jun; 182(11):7131-45. PubMed ID: 19454710
[TBL] [Abstract][Full Text] [Related]
9. Viral reservoirs and HIV-specific immunity.
Blankson JN
Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
[TBL] [Abstract][Full Text] [Related]
11. Role of the gastrointestinal tract in establishing infection in primates and humans.
Mehandru S; Dandekar S
Curr Opin HIV AIDS; 2008 Jan; 3(1):22-7. PubMed ID: 19372940
[TBL] [Abstract][Full Text] [Related]
12. Acute HIV infection: it takes more than guts.
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jan; 1(1):10-5. PubMed ID: 19372777
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute HIV-1 infection: are we getting there?
Cellerai C; Little SJ; Loes SK
Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
15. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
Bowen JL; Olson JK
J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapies.
Chomont N; Trautmann L; Routy JP; Sékaly RP
Curr Opin HIV AIDS; 2007 Mar; 2(2):116-22. PubMed ID: 19372876
[TBL] [Abstract][Full Text] [Related]
17. Qualitative host factors associated with immunological control of HIV infection by CD8 T cells.
Migueles SA; Tilton JC; Connors M
Curr Opin HIV AIDS; 2006 Jan; 1(1):28-33. PubMed ID: 19372780
[TBL] [Abstract][Full Text] [Related]
18. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
Debre P; Costagliola D; Legrand R; Vieillard V
Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
[TBL] [Abstract][Full Text] [Related]
19. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
20. Probing the possibilities for T-cell-based AIDS vaccines.
Garber DA; Feinberg MB
Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
